Question 1

What is the catalog number for WDR13 (WD Repeat-containing Protein 13, MG21, DKFZp779C2057, FLJ20563)?

Accepted Answer

The catalog number for WDR13 (WD Repeat-containing Protein 13, MG21, DKFZp779C2057, FLJ20563) is 138489.

Question 2

What sizes are available for WDR13 (WD Repeat-containing Protein 13, MG21, DKFZp779C2057, FLJ20563)?

Accepted Answer

WDR13 (WD Repeat-containing Protein 13, MG21, DKFZp779C2057, FLJ20563) is available in the following size(s): 100 µg.

Question 3

Is WDR13 (WD Repeat-containing Protein 13, MG21, DKFZp779C2057, FLJ20563) in stock?

Accepted Answer

WDR13 (WD Repeat-containing Protein 13, MG21, DKFZp779C2057, FLJ20563) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

WDR13 (WD Repeat-containing Protein 13, MG21, DKFZp779C2057, FLJ20563)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

FOLH1 / PSMA (Prostate Epithelial Marker) (FOLH1/2121), CF488A conjugate, 0.1mg/mL

NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF740 conjugate, 0.1mg/mL

Heat Shock 27kDa Protein 1 (HPS27) (CPTC-HSPB1-2), 0.2mg/mL

CD50 (ICAM-3) (101-1D2), CF647 conjugate, 0.1mg/mL

CD79a (IGA/764), CF640R conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), 0.2mg/mL